Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

AriBio

Private

AriBio is a clinical-stage South Korean biopharmaceutical company developing oral therapies for neurodegenerative and inflammatory disease, with U.S. clinical operations in San Diego. Its lead candidate AR1001 (mirodenafil) is in global Phase 3 development for early Alzheimer's disease.

Company Info

Sector:Biopharmaceuticals
Headquarters:Seongnam, Gyeonggi, South Korea
Founded:2010

Clinical Development Pipeline

AR1001 (mirodenafil)

Target: PDE5 inhibitor
Early Alzheimer's disease
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Matthew (Jai Jun) Choung

Chairman and Chief Executive Officer

Careers & Job Openings

See all open roles

Clinical / Research
Seongnam, South Korea
Apply Now →